Mosquirix, a new vaccine
from GSK for malaria, along with
10 other new medicines, has
been approved by the European
Medicines Agency in the July
meeting of the Committee for
Medicinal Products for Human Use.
Other approvals included Praluent
(alirocumab) for cholesterol
lowering, Cresemba (isavuconazole)
for aspergillosis and mucormycosis,
Zerbaxa (ceftolozane/tazobactam)
for post-operative pain, Ivabradine
Anpharm (ivabradine) plus
two generic meds and some
recommendations for extensions of
indication.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 15
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.